105 | EaseMyTrip IPO Analysis by S P Tulsian | S P Tulsian | Apply | IPO |
375 | Windlas Biotech IPO Analysis by InvestorGain.com | InvestorGain.com | Apply | IPO |
458 | Vijaya Diagnostic IPO Analysis by InvestorGain.com | InvestorGain.com | Avoid | IPO |
606 | Tega Industries IPO Analysis by InvestorGain.com | InvestorGain.com | Apply | IPO |
324 | Tatva Chintan Pharma IPO Analysis by InvestorGain.com | InvestorGain.com | Apply | IPO |
566 | Tarsons Products IPO Analysis by InvestorGain.com | InvestorGain.com | Apply | IPO |
671 | Supriya Lifescience IPO Analysis by InvestorGain.com | InvestorGain.com | Apply | IPO |
590 | Star Health IPO Analysis by InvestorGain.com | InvestorGain.com | Avoid | IPO |
189 | Shyam Metalics IPO Analysis by InvestorGain.com | InvestorGain.com | May apply | IPO |
650 | Shriram Properties IPO Analysis by InvestorGain.com | InvestorGain.com | Avoid | IPO |
635 | RateGain IPO Analysis by InvestorGain.com | InvestorGain.com | Apply | IPO |
15 | RailTel IPO Analysis by InvestorGain.com | InvestorGain.com | May apply | IPO |
548 | PolicyBazaar IPO Analysis by InvestorGain.com | InvestorGain.com | Apply | IPO |
339 | Paytm IPO Analysis by InvestorGain.com | InvestorGain.com | Apply | IPO |
495 | Paras Defence and Space Technologies IPO Analysis by InvestorGain.com | InvestorGain.com | Apply | IPO |
538 | Nykaa IPO Analysis by InvestorGain.com | InvestorGain.com | Apply | IPO |
361 | Nuvoco IPO Analysis by InvestorGain.com | InvestorGain.com | Avoid | IPO |
74 | Nureca limited IPO Analysis by InvestorGain.com | InvestorGain.com | Avoid | IPO |
93 | MTAR Technologies IPO Analysis by InvestorGain.com | InvestorGain.com | May apply | IPO |
656 | Metro Brands IPO Analysis by InvestorGain.com | InvestorGain.com | Apply | IPO |
666 | Medplus Health IPO Analysis by InvestorGain.com | InvestorGain.com | May apply | IPO |
628 | MapmyIndia IPO Analysis by InvestorGain.com | InvestorGain.com | Apply | IPO |
132 | Laxmi Organic IPO Analysis by InvestorGain.com | InvestorGain.com | May apply | IPO |
561 | Latent View Analytics IPO Analysis by InvestorGain.com | InvestorGain.com | Apply | IPO |
416 | Krsnaa Diagnostics IPO Analysis by InvestorGain.com | InvestorGain.com | Apply | IPO |
26 | IRFC IPO Analysis by InvestorGain.com | InvestorGain.com | Apply | IPO |
46 | Indigo Paints IPO Analysis by InvestorGain.com | InvestorGain.com | Apply | IPO |
660 | HP Adhesive IPO Analysis by InvestorGain.com | InvestorGain.com | Avoid | IPO |
578 | GoColors IPO Analysis by InvestorGain.com | InvestorGain.com | Apply | IPO |
511 | Fino Payments Bank IPO Analysis by InvestorGain.com | InvestorGain.com | Apply | IPO |
106 | EaseMyTrip IPO Analysis by InvestorGain.com | InvestorGain.com | Apply | IPO |
676 | CMS Info Systems IPO Analysis by InvestorGain.com | InvestorGain.com | May apply | IPO |
433 | Chemplast Sanmar IPO Analysis by InvestorGain.com | InvestorGain.com | Avoid | IPO |
408 | CarTrade Tech IPO Analysis by InvestorGain.com | InvestorGain.com | Apply | IPO |
615 | Anand Rathi IPO Analysis by InvestorGain.com | InvestorGain.com | May apply | IPO |
443 | Ami Organics IPO Analysis by InvestorGain.com | InvestorGain.com | Apply | IPO |
477 | Aditya Birla Sun Life AMC IPO Analysis by InvestorGain.com | InvestorGain.com | Apply | IPO |
309 | Zomato IPO review | Dilip Davda | Avoid | IPO |
373 | Windlas Bio IPO review | Dilip Davda | May apply | IPO |
447 | Vijaya Diagnostic IPO review | Dilip Davda | May apply | IPO |
598 | Tega Industries IPO review | Dilip Davda | Apply | IPO |
318 | Tatva Chintan IPO review | Dilip Davda | Apply | IPO |
563 | Tarsons Products IPO review | Dilip Davda | Apply | IPO |
154 | Suryoday Small Finance IPO review | Dilip Davda | May apply | IPO |
669 | Supriya Lifescience IPO review | Dilip Davda | Apply | IPO |
62 | Stove Kraft IPO review | Dilip Davda | May apply | IPO |
584 | Star Health Insurance IPO review | Dilip Davda | Avoid | IPO |
204 | Sona BLW Precision IPO review | Dilip Davda | May apply | IPO |
516 | S J S Enterprises IPO review | Dilip Davda | May apply | IPO |
550 | Sigachi Ind IPO review | Dilip Davda | Apply | IPO |
183 | Shyam Metalics IPO review | Dilip Davda | May apply | IPO |
648 | Shriram Properties IPO review | Dilip Davda | May apply | IPO |
555 | Sapphire Foods IPO review | Dilip Davda | May apply | IPO |
464 | Sansera Engineering IPO review | Dilip Davda | Apply | IPO |
342 | Rolex Rings IPO review | Dilip Davda | Apply | IPO |
632 | Rategain Travel IPO review | Dilip Davda | May apply | IPO |
6 | RailTel Corp IPO review | Dilip Davda | May apply | IPO |
193 | POWERGRID Infra InvIT issue review | Dilip Davda | May apply | IPO |
542 | PB Fintech IPO review | Dilip Davda | May apply | IPO |
333 | One 97 Commu (PayTM) IPO review | Dilip Davda | May apply | IPO |
485 | Paras Defence IPO review | Dilip Davda | May apply | IPO |
527 | FSN E-comm (NYKAA) IPO review | Dilip Davda | May apply | IPO |
353 | Nuvoco Vistas IPO review | Dilip Davda | May apply | IPO |
71 | Nureca Ltd IPO review | Dilip Davda | May apply | IPO |
111 | Nazara Techno IPO review | Dilip Davda | May apply | IPO |
88 | MTAR Techno IPO review | Dilip Davda | May apply | IPO |
653 | Metro Brands IPO review | Dilip Davda | May apply | IPO |
664 | MedPlus Health IPO review | Dilip Davda | May apply | IPO |
620 | C. E. Info Systems IPO review | Dilip Davda | May apply | IPO |
172 | Macrotech Developers (Lodha) IPO review | Dilip Davda | May apply | IPO |
127 | Laxmi Organic IPO review | Dilip Davda | May apply | IPO |
559 | Latent View IPO review | Dilip Davda | Apply | IPO |
412 | Krsnaa Diagno IPO review | Dilip Davda | May apply | IPO |
223 | Krishna Institute (KIMS) IPO review | Dilip Davda | May apply | IPO |
149 | Kalyan Jewellers IPO review | Dilip Davda | May apply | IPO |
19 | Indian Railway Finance IPO review | Dilip Davda | May apply | IPO |
32 | Indigo Paints IPO review | Dilip Davda | May apply | IPO |
236 | India Pesticides IPO review | Dilip Davda | Apply | IPO |
658 | HP Adhesives IPO review | Dilip Davda | May apply | IPO |
53 | Home First Finance IPO review | Dilip Davda | May apply | IPO |
78 | Heranba Ind IPO review | Dilip Davda | May apply | IPO |
572 | Go Fashion (Go Colors) IPO review | Dilip Davda | May apply | IPO |
295 | Glenmark Life IPO review | Dilip Davda | May apply | IPO |
255 | G R Infra IPO review | Dilip Davda | May apply | IPO |
503 | Fino Payments IPO review | Dilip Davda | May apply | IPO |
367 | Exxaro Tiles IPO review | Dilip Davda | May apply | IPO |
99 | Easy Trip Planners IPO review | Dilip Davda | May apply | IPO |
218 | Dodla Dairy IPO review | Dilip Davda | May apply | IPO |
384 | Devyani Intl IPO review | Dilip Davda | May apply | IPO |
638 | Data Patterns IPO review | Dilip Davda | Apply | IPO |
118 | Craftsman Automation IPO review | Dilip Davda | May apply | IPO |
675 | CMS Info IPO review | Dilip Davda | Apply | IPO |
277 | Clean Science IPO review | Dilip Davda | May apply | IPO |
431 | Chemplast Sanmar IPO review | Dilip Davda | May apply | IPO |
399 | CarTrade Tech IPO review | Dilip Davda | May apply | IPO |
66 | Brookfield India Real (ReITs) review | Dilip Davda | May apply | IPO |
161 | Barbeque Nation IPO review | Dilip Davda | May apply | IPO |
422 | Aptus Value IPO review | Dilip Davda | May apply | IPO |
140 | Anupam Rasayan IPO review | Dilip Davda | May apply | IPO |
610 | Anand Rathi Wealth IPO review | Dilip Davda | May apply | IPO |
437 | Ami Organics IPO review | Dilip Davda | May apply | IPO |
472 | Aditya Birla Sun Life AMC IPO review | Dilip Davda | Apply | IPO |
631 | Rategain Travel Technologies Limited IPO Analysis by Capital Market | Capital Market | May apply | IPO |
571 | Go Fashion (India) Limited IPO Analysis by Capital Market | Capital Market | Neutral | IPO |
526 | FSN E-Commerce Ventures Limited IPO Analysis by Capital Market | Capital Market | May apply | IPO |
502 | Fino Payments Bank Limited IPO Analysis by Capital Market | Capital Market | Neutral | IPO |
657 | HP Adhesives Limited IPO Analysis by Capital Market | Capital Market | Neutral | IPO |
446 | Vijaya Diagnostic IPO Analysis by Capital Market | Capital Market | Avoid | IPO |
293 | Glenmark Life Sciences IPO Analysis by Capital Market | Capital Market | May apply | IPO |
317 | Tatva Chintan Pharma IPO Analysis by Capital Market | Capital Market | May apply | IPO |
483 | Paras Defence and Space Technologies IPO Analysis by Capital Market | Capital Market | May apply | IPO |
234 | India Pesticides IPO Analysis by Capital Market | Capital Market | Avoid | IPO |
549 | Sigachi Industries Limited IPO Analysis by Capital Market | Capital Market | May apply | IPO |
97 | EaseMyTrip IPO Analysis by Capital Market | Capital Market | Apply | IPO |
436 | Ami Organics IPO Analysis by Capital Market | Capital Market | May apply | IPO |
366 | Exxaro Tiles IPO Analysis by Capital Market | Capital Market | May apply | IPO |
554 | Sapphire Foods India Limited IPO Analysis by Capital Market | Capital Market | Neutral | IPO |
411 | Krsnaa Diagnostics IPO Analysis by Capital Market | Capital Market | Avoid | IPO |
51 | Home First Finance IPO Analysis by Capital Market | Capital Market | Apply | IPO |
515 | S.J.S. Enterprises Limited IPO Analysis by Capital Market | Capital Market | Neutral | IPO |
307 | Zomato IPO Analysis by Capital Market | Capital Market | May apply | IPO |
609 | Anand Rathi Wealth Limited IPO Analysis by Capital Market | Capital Market | Avoid | IPO |
138 | Anupam Rasayan IPO Analysis by Capital Market | Capital Market | Avoid | IPO |
276 | Clean Science IPO Analysis by Capital Market | Capital Market | Apply | IPO |
647 | Shriram Properties Limited IPO Analysis by Capital Market | Capital Market | Neutral | IPO |
398 | CarTrade Tech IPO Analysis by Capital Market | Capital Market | May apply | IPO |
153 | Suryoday Small Finance Bank IPO Analysis by Capital Market | Capital Market | Avoid | IPO |
182 | Shyam Metalics IPO Analysis by Capital Market | Capital Market | Apply | IPO |
674 | CMS Info Systems Limited IPO Analysis by Capital Market | Capital Market | May apply | IPO |
420 | Aptus Value Housing Finance IPO Analysis by Capital Market | Capital Market | May apply | IPO |
61 | Stove Kraft IPO Analysis by Capital Market | Capital Market | Avoid | IPO |
30 | Indigo Paints IPO Analysis by Capital Market | Capital Market | Apply | IPO |
148 | Kalyan Jewellers IPO Analysis by Capital Market | Capital Market | Avoid | IPO |
217 | Dodla Dairy IPO Analysis by Capital Market | Capital Market | Avoid | IPO |
541 | PB Fintech Limited IPO Analysis by Capital Market | Capital Market | Neutral | IPO |
332 | One 97 Communications Limited IPO Analysis by Capital Market | Capital Market | Neutral | IPO |
637 | Data Patterns (India) Limited IPO Analysis by Capital Market | Capital Market | May apply | IPO |
558 | Latent View Analytics Limited IPO Analysis by Capital Market | Capital Market | Neutral | IPO |
462 | Sansera Engineering IPO Analysis by Capital Market | Capital Market | Avoid | IPO |
372 | Windlas Biotech IPO Analysis by Capital Market | Capital Market | Avoid | IPO |
170 | Lodha Developers IPO Analysis by Capital Market | Capital Market | Avoid | IPO |
253 | G R Infraprojects IPO Analysis by Capital Market | Capital Market | Apply | IPO |
596 | Tega Industries Limited IPO Analysis by Capital Market | Capital Market | May apply | IPO |
222 | KIMS IPO Analysis by Capital Market | Capital Market | Avoid | IPO |
663 | Medplus Health Services Limited IPO Analysis by Capital Market | Capital Market | May apply | IPO |
562 | Tarsons Products Limited IPO Analysis by Capital Market | Capital Market | May apply | IPO |
87 | MTAR Technologies IPO Analysis by Capital Market | Capital Market | Apply | IPO |
582 | Star Health and Allied Insurance Company Ltd IPO Analysis by Capital Market | Capital Market | Neutral | IPO |
110 | Nazara Technologies IPO Analysis by Capital Market | Capital Market | Apply | IPO |
159 | Barbeque Nation IPO Analysis by Capital Market | Capital Market | Avoid | IPO |
341 | Rolex Rings IPO Analysis by Capital Market | Capital Market | May apply | IPO |
77 | Heranba Industries IPO Analysis by Capital Market | Capital Market | Apply | IPO |
117 | Craftsman Automation IPO Analysis by Capital Market | Capital Market | Apply | IPO |
382 | Devyani International IPO Analysis by Capital Market | Capital Market | May apply | IPO |
126 | Laxmi Organic IPO Analysis by Capital Market | Capital Market | Apply | IPO |
352 | Nuvoco IPO Analysis by Capital Market | Capital Market | Avoid | IPO |
471 | Aditya Birla Sun Life AMC IPO Analysis by Capital Market | Capital Market | May apply | IPO |
430 | Chemplast Sanmar IPO Analysis by Capital Market | Capital Market | Avoid | IPO |
202 | Sona Comstar IPO Analysis by Capital Market | Capital Market | Apply | IPO |
652 | Metro Brands Limited IPO Analysis by Capital Market | Capital Market | Neutral | IPO |
18 | IRFC IPO Analysis by Capital Market | Capital Market | Apply | IPO |
315 | Zomato IPO Analysis by Ventura Securities Limited | Ventura Securities Limited | Apply | IPO |
314 | Zomato IPO Analysis by Sharekhan Limited | Sharekhan Limited | Neutral | IPO |
313 | Zomato IPO Analysis by Religare Broking Limited | Religare Broking Limited | Neutral | IPO |
312 | Zomato IPO Analysis by KR Choksey Securities Ltd | KR Choksey Securities Ltd | Apply | IPO |
311 | Zomato IPO Analysis by ICICI Securities | ICICI Securities | Neutral | IPO |
310 | Zomato IPO Analysis by GEPL Capital Ltd | GEPL Capital Ltd | Apply | IPO |
308 | Zomato IPO Analysis by Choice Equity Broking Pvt Ltd | Choice Equity Broking Pvt Ltd | May apply | IPO |
306 | Zomato IPO Analysis by Axis Capital | Axis Capital | Neutral | IPO |
305 | Zomato IPO Analysis by Ambit Capital Pvt Ltd | Ambit Capital Pvt Ltd | Neutral | IPO |
374 | Windlas Biotech IPO Analysis by JM Financial Institutional Securities | JM Financial Institutional Securities | Neutral | IPO |
459 | Vijaya Diagnostic IPO Analysis by Ventura Securities Limited | Ventura Securities Limited | Apply | IPO |
456 | Vijaya Diagnostic IPO Analysis by Reliance Securities | Reliance Securities | Apply | IPO |
455 | Vijaya Diagnostic IPO Analysis by Mehta Equities | Mehta Equities | Apply | IPO |
454 | Vijaya Diagnostic IPO Analysis by Marwadi Shares and Finance Limited | Marwadi Shares and Finance Ltd | Apply | IPO |
453 | Vijaya Diagnostic IPO Analysis by KR Choksey Securities Ltd | KR Choksey Securities Ltd | Apply | IPO |
444 | Vijaya Diagnostic IPO Analysis by Arihant Capital Markets Ltd | Arihant Capital Markets Ltd | Apply | IPO |
457 | Vijaya Diagnostic IPO Analysis by Religare Broking Limited | Religare Broking Limited | Neutral | IPO |
452 | Vijaya Diagnostic IPO Analysis by Kotak Securities | Kotak Securities | Neutral | IPO |
451 | Vijaya Diagnostic IPO Analysis by JM Financial Institutional Securities | JM Financial Institutional Securities | Neutral | IPO |
450 | Vijaya Diagnostic IPO Analysis by IIFL Securities | IIFL Securities | Apply | IPO |
449 | Vijaya Diagnostic IPO Analysis by Hem Securities | Hem Securities | Apply | IPO |
448 | Vijaya Diagnostic IPO Analysis by HDFC Securities Limited | HDFC Securities Limited | Neutral | IPO |
347 | Rolex Rings IPO Analysis by Ventura Securities Limited | Ventura Securities Limited | Apply | IPO |
178 | Lodha Developers IPO Analysis by Ventura Securities Limited | Ventura Securities Limited | Not Rated | IPO |
605 | Tega Industries IPO Analysis by Religare Broking Limited | Religare Broking Limited | Neutral | IPO |
604 | Tega Industries IPO Analysis by Marwadi Shares and Finance Limited | Marwadi Shares and Finance Ltd | Apply | IPO |
603 | Tega Industries IPO Analysis by Kotak Securities | Kotak Securities | Neutral | IPO |
602 | Tega Industries IPO Analysis by Investmentz Ltd | Investmentz Ltd | Apply | IPO |
601 | Tega Industries IPO Analysis by ICICI Direct | ICICI Direct | Apply | IPO |
600 | Tega Industries IPO Analysis by Hem Securities | Hem Securities | Apply | IPO |
599 | Tega Industries IPO Analysis by HDFC Securities Limited | HDFC Securities Limited | Neutral | IPO |
597 | Tega Industries IPO Analysis by Choice Equity Broking Pvt Ltd | Choice Equity Broking Pvt Ltd | Apply | IPO |
595 | Tega Industries IPO Analysis by Canara Bank | Canara Bank | Neutral | IPO |
594 | Tega Industries IPO Analysis by BP Equities (BP Wealth) | BP Equities (BP Wealth) | Apply | IPO |
593 | Tega Industries IPO Analysis by Axis Capital | Axis Capital | Neutral | IPO |
592 | Tega Industries IPO Analysis by Ashika Research | Ashika Research | Apply | IPO |
591 | Tega Industries IPO Analysis by Angel One | Angel One | Apply | IPO |
322 | Tatva Chintan Pharma IPO Analysis by Reliance Securities | Reliance Securities | Apply | IPO |
323 | Tatva Chintan Pharma IPO Analysis by Sharekhan Limited | Sharekhan Limited | Neutral | IPO |
1 of 4 Next Last |